Activation of CD8+ T cells in vitro upregulated the expression level of Rig-I, which led to cell death and compromised cytotoxicity, while tumor-bearing mice transferred with Rig-I-deficient CD8+ T cells exhibited delayed tumor growth. Here, RIGI is linked to neoplasm.